Trial Profile
A Phase I Trial of Lenalidomide and Radiotherapy in Children With Diffuse Intrinsic Pontine Gliomas and High-grade Gliomas
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Dec 2021
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary)
- Indications Anaplastic astrocytoma; Glioblastoma; Glioma
- Focus Adverse reactions
- 18 Apr 2019 Status changed from active, no longer recruiting to completed.
- 18 Apr 2019 Status changed from active, no longer recruiting to completed.
- 18 Nov 2017 Planned End Date changed from 30 Jan 2018 to 30 Apr 2021.